scanance.
Sign inGet Premium
DD

DuPont de Nemours, Inc.

DDBasic MaterialsNASDAQ

Specialty Chemicals

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$6.85B
+1.9% YoY
Net Income
-$779.0M
-210.8% YoY
EBITDA
$1.16B
+3.8% YoY
Free Cash Flow
-$124.8M

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About DuPont de Nemours, Inc.

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. At a $19.33B market cap, DuPont de Nemours, Inc. ranks as a large-cap company within basic materials. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials.

Key stats
Market Cap$19.33B
P/E (TTM)125.55
Fwd P/E18.23
EPS$0.38
Beta1.06
52W Change+70.7%
Dividend Yield1.68%
ROE0.9%
Analysis

On the balance sheet, DD has $710.0M in cash with $3.22B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow is running at -$124.8M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at 0.9%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $13.02B to $6.85B.

The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence DuPont de Nemours, Inc.'s trajectory.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms